Processa Pharmaceuticals, Inc. — Investor Relations & Filings
Processa Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing treatments for patients with unmet medical needs in life-threatening and chronic diseases. The company's primary area of development is oncology, where it aims to improve the safety and efficacy of existing chemotherapy drugs through its Next Generation Cancer (NGC) therapies. Its pipeline includes PCS6422 for metastatic colorectal and breast cancer, PCS499 for Ulcerative Necrobiosis Lipoidica, and PCS12852 for gastroparesis and gastrointestinal motility disorders. Processa utilizes a regulatory science approach to efficiently advance its drug candidates through the development and approval process, with the goal of improving patient survival and quality of life.
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
6 filings
| |||||
| 32893517 | 8-K - PROCESSA PHARMACEUTICALS, INC. (0001533743) (Filer) | 2026-02-19 | English | ||
| 30424848 | 4 Filing | 2026-02-04 | English | ||
| 30424766 | 4 Filing | 2026-02-04 | English | ||
| 30424748 | 4 Filing | 2026-02-04 | English | ||
| 30424734 | 4 Filing | 2026-02-04 | English | ||
| 12503664 | 8-K | 2026-01-07 | English | ||
|
2025
9 filings
| |||||
| 12503665 | 8-K | 2025-12-15 | English | ||
| 12503666 | Major Shareholding Notification 2025 | 2025-11-07 | English | ||
| 12503669 | 10-Q | 2025-11-06 | English | ||
| 12503670 | Major Shareholding Notification 2025 | 2025-10-15 | English | ||
| 12503671 | Director's Dealing 2025 | 2025-10-03 | English | ||
| 12503672 | Director's Dealing 2025 | 2025-10-03 | English | ||
| 12503673 | Director's Dealing 2025 | 2025-10-03 | English | ||
| 12503674 | Director's Dealing 2025 | 2025-10-03 | English | ||
| 12503675 | Director's Dealing 2025 | 2025-10-03 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Aclaris Therapeutics, Inc.
Clinical-stage biopharmaceutical company developing drugs f…
|
ACRS | US | Manufacturing |
|
Acrivon Therapeutics, Inc.
Clinical-stage biopharma using proteomics to develop precis…
|
ACRV | US | Manufacturing |
|
ACRUX LIMITED
Develops and commercializes topical and transdermal drug de…
|
ACR | AU | Manufacturing |
|
Acticor Biotech
Develops treatments for thrombotic diseases, focusing on ac…
|
ALACT | FR | Manufacturing |
|
Actinium Pharmaceuticals, Inc.
Clinical-stage company developing targeted radiotherapies f…
|
ATNM | US | Manufacturing |
|
ACTUATE THERAPEUTICS, INC.
Clinical-stage biopharma developing therapies for cancers w…
|
ACTU | US | Manufacturing |
|
AcuCort AB
Develops user-friendly drug formulations for severe and acu…
|
ACUC | SE | Manufacturing |
|
Acumen Pharmaceuticals, Inc.
Clinical-stage biopharma developing targeted therapies for …
|
ABOS | US | Manufacturing |
|
Acurx Pharmaceuticals, Inc.
Clinical-stage biopharma developing a new class of antibiot…
|
ACXP | US | Manufacturing |
|
Adaptimmune Therapeutics PLC
Commercial-stage biopharma developing TCR T-cell therapies …
|
ADAP | GB | Manufacturing |
Processa Pharmaceuticals, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35172/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35172 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35172 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35172 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35172}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Processa Pharmaceuticals, Inc. (id: 35172)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.